SUBRENAL CAPSULE ASSAY TO TEST THE VIABILITY OF PARENTERALLY DELIVERED MULLERIAN INHIBITING SUBSTANCE

被引：15

作者：

DONAHOE, PK

KRANE, I

BOGDEN, AE

KAMAGATA, S

BUDZIK, GP

机构：

[1] MASSACHUSETTS GEN HOSP,DEPT SURG,PEDIAT SURG RES LAB,BOSTON,MA 02114

[2] EG&G BOGDEN LABS,WORCESTER,MA 01604

来源：

JOURNAL OF PEDIATRIC SURGERY | 1984年 / 19卷 / 06期

关键词：

D O I：

10.1016/S0022-3468(84)80386-3

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：863 / 869

页数：7

共 27 条

[1]

AUERBACH R, 1976, CANCER RES, V36, P3435

[2]

BOGDEN AE, 1979, EXP CELL BIOL, V47, P281

[3]

BOGDEN AE, 1981, CANCER, V48, P10, DOI 10.1002/1097-0142(19810701)48:1<10::AID-CNCR2820480105>3.0.CO

[4]

2-I

[5]

BOGDEN AE, 1978, P S USE ATHYMIC NUDE, P231

[6] MULLERIAN INHIBITING SUBSTANCE FRACTIONATION BY DYE AFFINITY-CHROMATOGRAPHY [J].

BUDZIK, GP ;

POWELL, SM ;

KAMAGATA, S ;

DONAHOE, PK .

CELL, 1983, 34 (01) :307-314

[7]

BUDZIK GP, DEV MECHANISMS NORMA

[8]

CUNHA GR, 1979, IN VITRO CELL DEV B, V15, P50

[9]

DONAHOE PK, 1982, RECENT PROG HORM RES, V38, P279

[10] MULLERIAN INHIBITING SUBSTANCE INHIBITS GROWTH OF A HUMAN OVARIAN-CANCER IN NUDE-MICE [J].

DONAHOE, PK ;

FULLER, AF ;

SCULLY, RE ;

GUY, SR ;

BUDZIK, GP .

ANNALS OF SURGERY, 1981, 194 (04) :472-480

← 1 2 3 →